Catalyst Edge · Scanner · Tickers · APM
CATALYST DOSSIER · UPDATED 2026-09-22

$APM

Unclassified · convergence — · conviction —
Convergence Score
—
Conviction
—
Signals Firing
0
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $APM?

APM -12 AVOID biotech

Quantitative

  • Convergence score: -12 (8 signals firing YoY)

Catalysts

  • Deal terms: licensing_agreement 2026-07-20

Risks

  • Position-sizing discipline: Conviction AVOID (-12 score) — size accordingly; no specific catalyst-fade risk flagged

Bear case

  • Orphan-aggregator sector lean against: Sector biotech aggregating -2 from 31 alt-data spokes

Sympathy basket (cerebro)

  • VRT via semis r=+0.80 sympathetic (score 20)
  • FLEX via semis r=+0.80 sympathetic (score 7)
  • NMRK via real_estate r=-0.75 divergent (score 5)
  • FREI via real_estate r=-0.75 divergent (score 3)
  • ASAN via tech r=+0.58 sympathetic (score 11)
  • BLKB via tech r=+0.58 sympathetic (score 7)

Signals Firing

No active signals this cycle.
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.